Psychological and quality of life effects of vaccination against COVID-19 in patients with systemic autoimmune diseases

Please use this identifier to cite or link to this item:
Información del item - Informació de l'item - Item information
Title: Psychological and quality of life effects of vaccination against COVID-19 in patients with systemic autoimmune diseases
Authors: Montero-López, Eva | Peralta-Ramírez, María Isabel | Ortego-Centeno, Norberto | Callejas-Rubio, José Luis | Ríos-Fernández, Raquel | Santos-Ruiz, Ana
Research Group/s: Psicología Aplicada a la Salud y Comportamiento Humano (PSYBHE) | Calidad de Vida, Bienestar Psicológico y Salud
Center, Department or Service: Universidad de Alicante. Departamento de Psicología de la Salud
Keywords: Autoimmune diseases | COVID-19 | Psychological status | Quality of life | Vaccine
Issue Date: 10-Nov-2022
Publisher: SAGE Publications
Citation: Lupus. 2022, 31(14): 1808-1815.
Abstract: To verify the psychological and quality of life benefits of vaccination against COVID-19 in patients with systemic autoimmune diseases. In this study, levels of psychological stress, psychopathological symptoms, quality of life, and satisfaction with life were compared in patients with systemic autoimmune diseases vaccinated against COVID-19 (n = 132) versus unvaccinated patients (n = 254). To this end, we used the Perceived Stress Scale (PSS), Symptom Checklist-90-Revised (SCL-90-R), EUROQoL-5Q health questionnaire, and Satisfaction with Life Scale (SWLS), respectively. Statistically significant differences were found with better scores in the vaccinated group in the following quality of life dimensions: mobility (p ≤ 0.010), domestic activities (p ≤ 0.004), pain/discomfort (p ≤ 0.001), and anxiety/depression (p≤ 0.005). The scores were also significantly higher in the vaccinated group for the total values of quality of life (p ≤ 0.001), health status self-assessment on the EUROQoL-5Q (p ≤ 0.043), and satisfaction with life (p ≤ 0.015). In addition, the unvaccinated group presented higher scores with clinically pathological levels in depression and psychoticism for somatizations (p ≤ 0.006), depression (p ≤ 0.015), anxiety (p ≤ 0.003), and phobic anxiety (p ≤ 0.001). Finally, participants vaccinated with the complete regimen showed better levels of psychological well-being than those who were not vaccinated or those that had not completed the vaccination regimen. Our results reflect and confirm the positive effects reported elsewhere of the COVID-19 vaccine in autoimmune patients with systemic diseases, both in terms of quality and satisfaction with life as well as psychopathological symptoms and perceived stress. These benefits increased as the patients completed their vaccination schedule.
ISSN: 0961-2033 (Print) | 1477-0962 (Online)
DOI: 10.1177/09612033221134203
Language: eng
Type: info:eu-repo/semantics/article
Rights: © The Author(s) 2022
Peer Review: si
Publisher version:
Appears in Collections:INV - PSYBHE - Artículos de Revistas
INV - CV, BP Y S - Artículos de Revistas

Files in This Item:
Files in This Item:
File Description SizeFormat 
ThumbnailMontero-Lopez_etal_2022_Lupus_final.pdfVersión final (acceso restringido)672,57 kBAdobe PDFOpen    Request a copy

Items in RUA are protected by copyright, with all rights reserved, unless otherwise indicated.